Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3532-3536

  Brian De Souza, J ^a   Ling, Irene T ^b   Ogun, Sola A ^b   Holder, Anthony A ^b   Playfair, John H L ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; MEMBRANE PROTEIN; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; CONTROLLED STUDY; HELPER CELL; IMMUNOFLUORESCENCE; IMMUNOGENICITY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SURVIVAL; VACCINATION;

EID: 9544250398     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3532-3536.1996     Document Type: Article

References (28)

1. Calvo, P. A., T. M. Daly, and C. A. Long. 1996. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria. Exp. Parasitol. 82:54-64.
2. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61: 2462-2467.
3. de Souza, J. B., and J. H. L. Playfair. 1995. A novel adjuvant for use with a blood-stage malaria vaccine. Vaccine 13:1316-1319.
4. Finkelman, F. D., I. M. Kalona, T. R. Mossmann, and R. L. Coffman. 1988. IFNγ regulates the isotypcs of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022-1027.
5. Freeman, R. R., and A. A. Holder. 1983. Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen. Clin. Exp. Immunol. 54:609-616.
6. Herrera, M. A., F. Rosero, S. Herrera, P. Caspers, D. Rotmann, F. Sinigaglia, and V. Certa. 1992. Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect. Immun. 60:154-158.
7. Herrington, D. A., G. A. Losonsky, G. Smith, F. Volvovitz, M. Cochran, K. Jackson, S. L. Hoffman, D. M. Gordon, M. M. Levine, and R. Edelman. 1992. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine 10:841-846.
8. Hui, G. S. N., and S. P. Chang. 1992. Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants. Exp. Parasitol. 75:155-157.
9. Hunter, R. L., M. R. Kidd, M. R. Olsen, P. S. Patterson, and A. A. Lal. 1995. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J. Immunol. 154:1762-1769.
10. + T-cells in the immune response to Plasmodium chabaudi. Parasitol. Today 5:362-364.
11. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. (Oxford) 16:63-67.
12. Livingston, P. O., S. Adluri, S. Raychaudhuri, M. H. Hughes, M. J. Calves, and J. A. Merritt. 1994. Phase I trial of immunological adjuvant SAFm in melanoma patients vaccinated with antiidiotype antibody MELIMMUNE-1. Vaccine Res. 3:71-81.
13. Majarian, W. R., T. M. Daly, W. P. Weidanz, and C. A. Long. 1984. Passive immunization against murine malaria with an IgG3 monoclonal antibody. J. Immunol. 132:3131-3137.
14. Nakane, A., A. Numata, and T. Minagawa. 1992. Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect. Immun. 60:523-528.
15. Patarroyo, M. E., R. Amador, P. Clavijo, A. Moreno, F. Guzman, P. Romero, R. Tascon, A. Franco, L. A. Murillo, G. Ponton, and G. Trujillo. 1988. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature (London) 332:158-161.
16. Patarroyo, M. E., P. Romero, M. L. Torres, P. Clavijo, A. Moreno, A. Martinez, R. Rodriguez, F. Guzman, and E. Cabezas. 1987. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (London) 328:629-632.
17. Perlmann, H., S. Kumar, J. M. Vinetz, M. Kullberg, L. H. Miller, and P. Perlmann. 1995. Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice. Infect. Immun. 63:3987-3993.
18. Playfair, J. H. L., and J. B. de Souza. 1979. Antibody responses in mice protected against malaria by vaccination. Parasite Immunol. (Oxford) 1:197-208.
19. Playfair, J. H. L., and J. B. de Souza. 1986. Vaccination of mice against malaria with soluble antigens. 1. The effect of detergent, route of injection, and adjuvant. Parasite Immunol. (Oxford) 8:409-414.
20. Raychaudhuri, S., M. Tonks, F. Carbone, T. Ryskamp, W. J. W. Morrow, and N. Hanna. 1992. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc. Natl. Acad. Sci. USA 89:8308-8312.
21. Riley, E. M., S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H. J. Schonfeld, A. A. Holder and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. (Oxford) 14:321-337.
22. + T cell subsets. Cell. Immunol. 129:80-94.
23. Stevenson, M. M., and M. F. Tam. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol. 92:77-83.
24. Stevenson, M. M., M. F. Tam, S. F. Wolfe, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
25. ten Hagen, T. L. M., A. J. Sulzer, M. R. Kidd, A. A. Lal, and R. L. Hunter. 1993. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J. Immunol. 12:7077-7085.
26. Voller, A., and P. O'Neil. 1971. Immunofluorescence method suitable for large scale application to malaria. Bull. W.H.O. 45:524-529.
27. Von der Weid, T., M. Kopf, G. Kohler, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 24:2285-2293.
28. Waki, S., S. Uehara, K. Kanabe, H. Nariuch, and M. Suzuki. 1995 Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice. Parasite Immunol. (Oxford) 17:503-508.